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ABSTRACT 
A stability-indicating reverse phase-HPLC method has been developed and validated for the simultaneous determination of 
Clobetasol  propionate  (CLOB)  and  Chlorocresol  (CHLOR)  in  pharmaceutical  dosage  form  (cream).  Beclomethasone 
dipropionate monohydrate (BEC) was used as internal standard. The column (Luna) C18 (250 mm × 4.6 mm, 5μm particle 
size)  was  used  for  chromatographic  separation.  The  gradient  elution  system  was  performed  using  mobile  phase  A: 
Ammonium dihydrogen phosphate pH 4.5 and methanol in the ratio of 80:30 respectively, and Acetonitrile as mobile phase 
B. The flow rate was adjusted to 1.5 ml/min. The column oven was set at 25°C and the detection wavelength at 240nm. The 
retention times of CHLOR, CLOB and BEC were found to be 8.86 min, 13.36 min and 15.6 min respectively. The linearity 
was performed in the concentration ranges of 64.0-96.0μg/ml (CHLOR), 32.0-48.0μg/ml (CLOB), and 80μg/ml (BEC) with 
squared correlation coefficient of 0.9995 and 0.9996 for CHLOR and CLOB respectively. The percentage purity of CHLOR 
and  CLOB  was  found  to  be  >  99.5  %.  The  analytical  method  has  been  validated  for  specificity,  linearity,  precision, 
accuracy, ruggedness and robustness which were found to be within the acceptance limit according to ICH guidelines. The 
developed method was successfully employed for routine and stability analysis of CHLOR and CLOB in pharmaceutical 
cream. 
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INTRODUCTION 
Chlorocresol (CHLOR), 4-Chloro-3-methylphenol [Fig. 1] is 
a preservative. Its molecular weight is 142.6g/mol  with an 
empirical  formula  C7H7ClO. 
[1]  CHLOR  is  a  bactericide, 
closely  related  to  carbolic  acid  used  in  the  formulation  of 
creams and ointments.
 [2] It is used
 as preservative in a large 
number of commercially available products and preparations 
such  as  metal  working  fluids,  construction  materials  and 
glue. 
[3-4]
  It  forms  colorless,  dimorphous  crystals  at  room 
temperature and is only slightly soluble in water. 
[5]
 Very few 
spectrophotometer methods were reported for determination 
of chlorocresol. 
[6]
 Also few HPLC methods were found for 
the  determination  of  chlorocresol. 
[2-5,  7-8]
  Clobetasol 
propionate  (CLOB),  Chemically  described  as  21-Chloro-9-
fluoro-11β-hydroxy-16 β-methyl-3,20-dioxopregna-1,4-dien-
17-yl  propanoate  [Fig.  2]  is  glucocorticoid.  Its  molecular 
weight is 467.0g/mol, with empirical formula C25H32ClFO5. 
[1] Clobetasol propionate is a potent topical glucocorticoid, 
white to almost white crystalline powder that is practically 
insoluble in water, freely soluble in acetone and in  
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dichloromethane  and  sparingly  soluble  in  ethanol. 
[9]  It  is 
about 1000 times more potent than hydrocortisone.
  [10] Few 
HPLC  methods  have  been  reported  for  the  estimation  of 
clobetasol.
  [9-14]  In  the  present  work  we  are  focused  on  to 
achieve  the  optimum  chromatographic  conditions  for  the 
simultaneous  determination  of  CHLOR  and  CLOB  in  the 
topical preparations. Beclomethasone dipropionate (BEC), 9-
Chloro-11β-hydroxy-16β-methyl-3,20-dioxopregna-1,4-dien-
17,21-diyl  dipropanoate  [Fig.  3]    is  glucocorticid.  Its 
molecular weight is 521.1 g/mol, and its empirical formula is 
C28H37ClO7. 
[1]  The  developed  method  can  be  applied 
successfully to quality control and stability testing purposes. 
To access the reproducibility and wide applicability of the 
developed method, it was validated as per ICH guidelines, 
which is mandatory also. 
[12-13, 15] 
 
MATERIALS AND METHODS  
Reagents and Chemicals  
Chlorocresol  was  purchased  from  SIGMA-ALDRICH, 
Clobetasol  propionate  from  SYMBIOTICA  and  BEC  Was 
purchased  from  USP.  All  chemicals  used  of  HPLC  grade: 
Acetonitrile and Methanol were purchased from J.T. Baker, 
Ammonium dihydrogen phosphate and phosphoric acid was 
purchased from Merck. Water used was freshly prepared by 
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Fig. 1: Chemical Structure for Chlorocresol 
 
Fig. 2: Chemical Structure for Clobetasol propionate 
 
Fig.  3:  Chemical  Structure  for  Beclomethasone  dipropionate 
monohydrate 
 
Table 1: Gradient Elution System  
Time(min)   Mobile phase A %   Mobile phase B %   Flow rate 
(ml/min)  
0   00   00   5.1  
50   00   00   5.1  
50   00   00   5.1  
00   00   00   5.1  
00   00   00   5.1  
 
Equipment and Chromatographic Conditions  
A  Dionex  UltiMate  3000  HPLC  system  with  Chromeleon 
software “version 6.8” and Photodiode Array Detector was 
used. It was manufactured by Dionex Corporation Company, 
USA.  The  column  (Luna)  C18  (250  mm  ×  4.6  mm,  5μm 
particle size) was used for analytical separation. The mobile 
phase consisted of mobile phase A: Ammonium dihydrogen 
phosphate buffer pH 4.5 and methanol in the ratio of 80:30, 
and  mobile  phase  B:  Acetonitrile.  The  gradient  elution 
system used was as described in Table 1. The flow rate was 
adjusted to 1.5 ml/min, column oven was operated at 25°C, 
UV  detection  was  achieved  at  240nm  and  the  injection 
volume was set to 20μL. Purity analysis was performed over 
a wavelength range of 200-400nm. 
Preparation of Analytical Solutions  
Preparation of Ammonium dihydrogen phosphate buffer  
Prepared  by  dissolving  3.0  g  of  ammonium  dihydrogen 
phosphate in 1000ml of distilled water, the pH was adjusted 
to  4.5  with  5%  ammonium  hydroxide  solution  or  5% 
phosphoric acid. 
Preparation of mobile phase A  
Mobile phase A was prepared by mixing 300 ml of Methanol 
and  800  ml  of  ammonium  dihydrogen  phosphate.  Filtered 
through 0.45μ filter under vacuum filtration and degassed in 
ultrasonic water bath for 2 minutes. 
Preparation of mobile phase B  
Acetonitrile  for  HPLC  filtered  through  0.45μ  filter  under 
vacuum filtration and degassed in ultrasonic water bath for 2 
minute. 
Preparation of BEC internal standard solution  
The  BEC  internal  standard  solution  was  prepared  by 
dissolving 20  mg of  USP BEC in 50  ml of  methanol and 
filtered  using  0.45μ  filter  to  obtain  a  solution  having  a 
concentration of 0.4 mg/ml. 
Preparation of system suitability solution  
The system suitability solution was prepared by transferring 
an equivalent to 80 mg of CHLOR standard, an equivalent to 
40 mg of CLOB and 1 mg of clobetasol related compound A 
to 100 ml volumetric flask, 10 ml of the resulting solution 
were diluted to 20 ml with methanol and mixed. 5 ml of the 
resulting  solution  and  5  ml  of  internal  standard  were 
transferred to 25 ml volumetric flask and diluted to volume 
with methanol. Mixed and filtered through 0.45μ filter. 
Preparation of CHLOR and CLOB standard solution  
The solution was prepared by dissolving an equivalent to 20 
mg CLOB and equivalent to 40 mg of CHLOR in 100 ml of 
methanol. 5 ml of the resulting solution and 5ml of internal 
standard  were  transferred  to  25  ml  volumetric  flask  and 
completed  to  volume  with  methanol.  Mixed  and  filtered 
through 0.45μ filter. 
Preparation of sample solution  
2.0 g of cream equivalent to 1.0 mg of CLOB and 2.0 mg of 
CHLOR were transferred to 50ml centrifuge tube. 10 ml of 
methanol were added and shook vigorously to dissolve the 
cream.  Centrifuged  at  6000  rpm  for  10  minutes  and  the 
supernatant  was  decanted  to  25  ml  volumetric  flask.  The 
procedure was repeated with another 10 ml of methanol. 5 ml 
of  internal  standard  were  added  and  the  volume  was 
completed  with  methanol  and  mixed.  The  solution  was 
passed through 0.45-μm filter to obtain a solution having a 
concentration of 0.04 mg/ml CLOB, 0.08 mg/ml of CHLOR 
and 0.08 mg/ml of BEC. 
HPLC-Method Development and Validation of  
The  analytical  variables  parameters  tested  were  including 
specificity,  linearity,  precision,  accuracy,  and  system 
suitability. 
Specificity of analytical method and peak purity  
The specificity and peak purity were carried out to determine 
whether  there  were  any  interference  due  to  presence  of 
impurities,  degradation  products  or  other  components  that 
may  be  present  in  retention  time  of  analytical  peaks  and 
affect  the  peak  purity  and  specificity  of  the  analytical 
method. Forced degradation studies were carried out by using 
2M  HCl,  0.5M  NaOH,  thermal  degradation,  Hydrogen 
peroxide and Photo degradation. 
Linearity  
The  linearity  of  the  method  was  established  by  spiking  a 
series  of  sample  mixtures  of  CHLOR  and  CLOB.  The 
solutions  of  five  different  concentration  levels  64.0-
96.0μg/ml (CHLOR), 32.0-48.0μg/ml (CLOB), and 80μg/ml 
(BEC) were injected into the HPLC system. The calibration 
curve was constructed for the standard solutions by plotting 
CHLOR  concentrations  against  their  corresponding  peak 
areas and CLOB concentrations against their corresponding 
CLOB  to  BEC  peak  area  ratios.  Linear  regressions  were 
applied and slope-a, intercept-b and correlation coefficient-
R
2 were determined. 
Precision and Ruggedness  
Six  independent  sample  preparations  from  a  single  lot  of 
formulation 80.0μg/ml for CHLOR, 40μg/ml for CLOB and 
80μg/ml  for  BEC  were  injected  into  HPLC  system,  the 
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and  %  RSD  were  calculated  while  ruggedness  was 
determined  by  injecting  six  independent  preparations 
prepared by another analyst into another HPLC system.  The 
retention times and peak areas were obtained and the mean 
and % RSD were calculated.  
Accuracy (per cent recovery) 
The accuracy study was performed on 80%, 100% and 120% 
of the analytical method target concentration of CHLOR and 
CLOB.  Standard  and  sample  solutions  were  injected  into 
HPLC  system  in  triplicate  and  percentage  recoveries  of 
CHLOR and CLOB were calculated. The areas of CHLOR 
and the ratio of peaks areas of CLOB to BEC at each level 
were used for calculation of % recovery.  
Robustness  
Robustness of the developed analytical method was tested by 
evaluating the effect of small variations in analytical method 
parameters such as changing in flow rate (± 6.6%), changing 
in column temperature (± 5°C), changing in wavelength (± 
5nm) and the ratio of mobile phase B (±5%). 
System suitability  
System suitability test  was carried out on freshly prepared 
standard  solution  of  CHLOR,  CLOB,  Clobetasol  related 
compound A and BEC and the values were recorded. 
 
RESULTS AND DISCUSSION 
The present analytical method is a new RP-HPLC method for 
the simultaneous determination of CHLOR and CLOB. 
 
Table 2: Linearity results 
CHLOR  (CLOB/BEC) 
CHLOR Conc. 
μg/ml 
peak area 
(mAu*min) 
CLOB Conc. 
μg/ml 
peak area 
ratio 
64  9.583  32  0.47350 
72  10.637  36  0.53046 
80  11.717  40  0.58180 
88  12.844  44  0.64204 
96  14.024  48  0.69624 
R
2  0.9995  R
2  0.9996 
Slope-a  0.1386  Slope-a  0.0139 
y-intercept  0.672  y-intercept  0.0277 
 
Table 3: System precision results 
 
CHLOR  (CLOB/BEC) 
CHLOR 
retention 
time (min) 
peak area 
(mAu*min) 
CLOB 
retention time 
(min) 
peak area 
ratio 
Statistics 
8.86  11.661  13.37  0.579483 
8.86  11.781  13.36  0.579843 
8.86  11.861  13.37  0.578804 
8.86  11.846  13.37  0.579701 
8.86  11.884  13.37  0.580200 
8.87  11.901  13.37  0.580375 
Average  8.861667  11.82233  13.36833  0.579734 
St. Dev.  0.004082  0.0892  0.004082  0.00056 
% RSD  0.046  0.755  0.031  0.097 
 
Table 4: Method precision results 
 
CHLOR  (CLOB/BEC) 
CHLOR 
retention 
time (min) 
peak area 
(mAu*min) 
CLOB 
retention time 
(min) 
peak area 
ratio 
Statistics 
8.87  11.671  13.36  0.578793 
8.86  11.821  13.36  0.578152 
8.87  11.801  13.37  0.581156 
8.86  11.846  13.37  0.578871 
8.86  11.794  13.37  0.579567 
8.86  11.891  13.37  0.581104 
Average  8.863333  11.804  13.36667  0.579607 
St. Dev.  0.005164  0.074054  0.005164  0.001262 
% RSD  0.058  0.627  0.039  0.218 
 
Table 5: Ruggedness results 
 
CHLOR  (CLOB/BEC) 
CHLOR 
retention 
time (min) 
peak area 
(mAu*min) 
CLOB 
retention 
time (min) 
peak area 
ratio 
Statistics 
8.87  11.907  13.38  0.582506 
8.88  11.937  13.39  0.579961 
8.88  11.952  13.39  0.581935 
8.88  11.904  13. 40  0.582296 
8.89  11.920  13.40  0.580998 
8.89  11.947  13.41  0.579757 
Average  8.881667  11.92783  13.395  0.581242 
St. Dev.  0.007528  0.020488  0.010488  0.001191 
% RSD  0.085  0.172  0.078  0.205 
 
Table 6: % Recovery for CHLOR 
Concentration at 
specific level 
Active drug 
added (mg) 
Recovered 
amount (mg) 
Mean 
recovered 
80%  64  64.60 
100.4%  100%  80  80.25 
120%  96  96.2 
 
Table 7: % Recovery for CLOB 
Concentration at 
specific level 
Active drug 
added (mg) 
Recovered 
amount (mg) 
Mean 
recovered 
80%  32  32.08 
100.15%  100%  40  39.9 
120%  48  48.2 
 
 
Fig. 4: Linerity plot for CHLOR 
 
Fig. 5: Linerity plot for CLOB 
 
Mobile phase A: Ammonium dihydrogen phosphate pH 4.5 
and  methanol  in  the  ratio  of  80:30  respectively),  and 
Acetonitrile  as  mobile  phase  B  in  a  gradient  elution  as 
described in Table 1. The column (Luna) C18 (250 mm × 4.6 
mm,  5μm  particle  size)  was  used  for  chromatographic 
separation. The flow rate was adjusted to 1.5 ml/min, column 
oven was operated at 25°C and the injection volume was set Turabi et al. / Simultaneous Determination of Clobetasol (as Propionate) and Chlorocresol in Cream…..…… 
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to 20μL. The linearity was determined as linearity regression 
of  the  claimed  analyte  concentrations  of  the  ranges  64.0-
96.0μg/ml (CHLOR), 32.0-48.0μg/ml (CLOB), and 80μg/ml 
(BEC).  The  calibration  curves  were  obtained  by  plotting 
CHLOR  concentrations  against  peak  areas  and  CLOB 
concentrations  against  ratios  of  peaks  areas  for  CLOB  to 
BEC. Linearity results, exhibited in Table 2 were linear and 
the  squared  correlation  coefficients  were  found  to  be  of 
0.9995 and 0.9996 for CHLOR and CLOB respectively. The 
purity analysis  was performed over a wavelength range of 
200-400nm. 
The  %  Relative  Standard  Deviation  for  system  precision 
exhibited in Table 3 was found to be 0.046 and 0.097, the % 
Relative Standard Deviation for method precision exhibited 
in  Table  4  was  found  to  be  0.058  and  0.218  and  the  % 
Relative  Standard  Deviation  for  ruggedness  exhibited  in 
Table 5 was found to be 0.172 and 0.205 for CHLOR and 
CLOB respectively. The accuracy study was performed on 
80%,  100%  and  120%  of  the  target  concentration.  The 
percentage  recoveries  were  found  to  be  100.4  %  and 
100.15% for CHLOR and CLOB respectively as exhibited in 
Tables 6 & 7.  
Table 8: Robustness results 
Analytical Parameter  Adjusted to 
CHLOR  (CLOB/BEC) 
CHLOR retention time  peak area (mAU.min)  CLOB retention time  peak area ratio 
Column Temp. (ºC) 
20  9.11  12.118  13.7  0.580335 
25  8.86  11.861  13.37  0.578804 
30  8.70  11.872  13.15  0.577139 
Flow rate (ml/min) 
1.4  9.20  12.835  13.83  0.57840 
1.5  8.86  11.861  13.37  0.578804 
1.6  8.56  11.216  13.04  0.580645 
Wavelength 
235  8.89  31.366  13.41  0.585273 
240  8.89  11.947  13.41  0.579757 
245  8.89  3.360  13.41  0.581194 
Max. Mobile phase B (%) 
55  9.36  11.936  15.02  0.577776 
60  8.86  11.861  13.37  0.578804 
65  8.52  12.001  12.39  0.580613 
 
Table 9: System suitability values 
CHLOR  CLOB  CLOB Rel. Comp A  BEC 
Theoretical plates  Tailing factor  Theoretical plates  Tailing factor  Theoretical plates  Tailing factor  Theoretical plates  Tailing factor 
50388  1.16  76070  1.19  65081  1.02  54470  1.160 
Resolution between CHLOR and CLOB  25.9 
Resolution between CLOB and CLOB Rel Comp A  2.8 
Resolution between CLOB Related Compound A and BEC  7.0 
 
 
Fig. 7: Chromatogram for Standard Solution 
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Fig. 9: Chromatogram for System Suitability 
 
The robustness  were carried out  with  minor but deliberate 
changes  in  parameters  i.e.,  detection  wavelength,  column 
temperature,  and  flow  rate  as  exhibited  in  Table  8. 
Theoretical plates and tailing factor were observed and were 
found to be 50388 and 76070 (theoretical plates) and 1.16 
and 1.19 (tailing factor) for CHLOR and CLOB respectively. 
The resolution was found to be 25.9 between CHLOR and 
CLOB, 2.8 between CLOB and clobetasol related compound 
A and 7.0 between clobetasol related compound A and BEC 
exhibited in Table 9.  And the Relative Standard Deviation in 
retention time were found to be 0.062% for CHLOR, 0.041 
% for CLOB, 0.039 % for clobetasol related compound A   
and  0.035  %  for  BEC.  Figures  (7,  8  and  9)  exhibit  the 
chromatograms  for Standard solution, Sample solution and 
System Suitability solution. 
Advantages of the prescribed analytical method 
 It can be used for the simultaneous determination of CHLOR 
and  CLOB  in  pharmaceutical  cream  which  reduces  the 
laboratory costs and its efficiency to separate the principal 
peaks  from  impurities  and  any  other  degradation  products 
that may be present in exipients matrix.  
 
In conclusion, the method can be used for the simultaneous 
determination  of  CHLOR  and  CLOB  in  pharmaceutical 
cream. The analytical method was developed and validated 
for  system  suitability  linearity,  specificity,  accuracy, 
robustness and ruggedness. All parameters tested were found 
to be within limits. The study indicates that the method has 
significant  advantages  in  term  of  good  resolution  between 
analytes,  high  purity  of  active  drug  peak  and  preservative 
peak, accuracy and precision. 
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